Inventor · disambiguated record
Jiaqiang Dong
Also filed as: DONG JIAQIANG
8 granted patents·7 pending applications·5 citations·filing 2006–2025
75Inventor score
Files withLUOXIN PHARMACEUTICAL SHANGHAI CO LTD7SHANGHAI HANSOH BIOMEDICAL CO LTD5BEIJING PEARL BIOTECHNOLOGY LLC1HOFFMANN LA ROCHE1LUOXIN HEALTHCARE SCIENCE AND TECH DEVELOPMENT BEIJING LTD1
Top patents by PatentIndex Score
15 records- 0177US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 0276US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 0362US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 0460US12497366B2Nitrogen-containing heterocyclic derivative inhibitor, preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Granted Dec 16, 2025·0 cites·15 claims
- 0557US2025059196A1Tricyclic derivative inhibitor, preparation method therefor, and application thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 0656US2024368123A1Aromatic ring-containing biological antagonist, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2022·Application pending·0 cites
- 0755US2025066360A1Pyridine-containing polycyclic derivative, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2023·Application pending·0 cites
- 0854US2025388578A1Nitrogen-containing heterocyclic derivative inhibitor, and preparation method therefor and use thereofSHANGHAI HANSOH BIOMEDICAL CO LTD·Filed 2025·Application pending·0 cites
- 0949US2020317660A1Quinazolinone Compound and Application ThereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Application pending·0 cites
- 1049US2022213060A1Crystal Form of Quinazolinone Compound and Preparation Method ThereforLUOXIN HEALTHCARE SCIENCE AND TECH DEVELOPMENT BEIJING LTD·Filed 2020·Application pending·0 cites
- 1147US10774081B2Indolo substituted piperidine compound as estrogen receptor down-regulatorLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
- 1247US7399769B2Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Jul 15, 2008·0 cites·14 claims
- 1339US11639355B2Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted May 2, 2023·0 cites·15 claims
- 1437US2019284192A1Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Application pending·0 cites
- 1526US10023593B2ALK kinase inhibitor, and preparation method and uses thereofBEIJING PEARL BIOTECHNOLOGY LLC·Filed 2015·Granted Jul 17, 2018·0 cites·37 claims
Join the waitlist — get patent alerts
Get an alert when Jiaqiang Dong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →